Review



h460 lung large cell carcinoma cell line  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 98
      Buy from Supplier

    Structured Review

    ATCC h460 lung large cell carcinoma cell line
    H460 Lung Large Cell Carcinoma Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 2583 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nci+h460/pmc13122445-72-32-61?v=ATCC
    Average 98 stars, based on 2583 article reviews
    h460 lung large cell carcinoma cell line - by Bioz Stars, 2026-08
    98/100 stars

    Images



    Similar Products

    h460 lung large cell carcinoma cell line  (ATCC)
    98
    ATCC h460 lung large cell carcinoma cell line
    H460 Lung Large Cell Carcinoma Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nci+h460/pmc13122445-72-32-61?v=ATCC
    Average 98 stars, based on 1 article reviews
    h460 lung large cell carcinoma cell line - by Bioz Stars, 2026-08
    98/100 stars
    		  Buy from Supplier
    nci h460  (Korean Cell Line Bank)
    86
    Korean Cell Line Bank nci h460
    Nci H460, supplied by Korean Cell Line Bank, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nci+h460/pmc13247315-59-6-7?v=Korean+Cell+Line+Bank
    Average 86 stars, based on 1 article reviews
    nci h460 - by Bioz Stars, 2026-08
    86/100 stars
    		  Buy from Supplier
    h460  (ATCC)
    98
    ATCC h460
    H460, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nci+h460/pm42103791-70-19-26?v=ATCC
    Average 98 stars, based on 1 article reviews
    h460 - by Bioz Stars, 2026-08
    98/100 stars
    		  Buy from Supplier
    h 460  (ATCC)
    98
    ATCC h 460
    H 460, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nci+h460/10__3390_slash_ijms27083705-242-20-21?v=ATCC
    Average 98 stars, based on 1 article reviews
    h 460 - by Bioz Stars, 2026-08
    98/100 stars
    		  Buy from Supplier
    ncih460  (ATCC)
    98
    ATCC ncih460
    Ncih460, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nci+h460/pm41997112-245-7-19?v=ATCC
    Average 98 stars, based on 1 article reviews
    ncih460 - by Bioz Stars, 2026-08
    98/100 stars
    		  Buy from Supplier
    htb  (ATCC)
    98
    ATCC htb
    Htb, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nci+h460/pm41997112-243-15-13?v=ATCC
    Average 98 stars, based on 1 article reviews
    htb - by Bioz Stars, 2026-08
    98/100 stars
    		  Buy from Supplier
    htb 177  (ATCC)
    98
    ATCC htb 177
    Htb 177, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nci+h460/pm41976117-323-0-14?v=ATCC
    Average 98 stars, based on 1 article reviews
    htb 177 - by Bioz Stars, 2026-08
    98/100 stars
    		  Buy from Supplier
    nci h460  (ATCC)
    98
    ATCC nci h460
    Selective activities of compounds 12 (dCDK9‐009) and 13 (dCDK9‐010) against TP53 wild‐type cancer cells. (A and B) Examination of dose‐dependent impacts of dCDK9‐009 and dCDK9‐010 in TP53 wild‐type HCT116, HT1080, <t>NCI‐H460,</t> and U87. Cells were treated with increasing concentrations of indicated compounds for 24 h. (C and D) Examination of impacts of dCDK9‐009 and dCDK9‐010 in non‐malignant HEK293T and mesenchymal stem cell line ASC52telo. Cells were treated with increasing concentrations of indicated compounds for 24 h. (E and F) Effect of dCDK9‐009 and dCDK9‐010 treatment on cellular viabilities of indicated cancer cell lines, as well as ASC52telo. IC 50 was presented as mean ± SD with three independent replicates. (G) Heatmap summarizing the IC 50 values of dCDK9‐009 and dCDK9‐010 across human cell lines tested in this study (related to E and F, Figures S3, S4, and S8).
    Nci H460, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nci+h460/pmc13066720-187-0-1?v=ATCC
    Average 98 stars, based on 1 article reviews
    nci h460 - by Bioz Stars, 2026-08
    98/100 stars
    		  Buy from Supplier

    Image Search Results


    Selective activities of compounds 12 (dCDK9‐009) and 13 (dCDK9‐010) against TP53 wild‐type cancer cells. (A and B) Examination of dose‐dependent impacts of dCDK9‐009 and dCDK9‐010 in TP53 wild‐type HCT116, HT1080, NCI‐H460, and U87. Cells were treated with increasing concentrations of indicated compounds for 24 h. (C and D) Examination of impacts of dCDK9‐009 and dCDK9‐010 in non‐malignant HEK293T and mesenchymal stem cell line ASC52telo. Cells were treated with increasing concentrations of indicated compounds for 24 h. (E and F) Effect of dCDK9‐009 and dCDK9‐010 treatment on cellular viabilities of indicated cancer cell lines, as well as ASC52telo. IC 50 was presented as mean ± SD with three independent replicates. (G) Heatmap summarizing the IC 50 values of dCDK9‐009 and dCDK9‐010 across human cell lines tested in this study (related to E and F, Figures S3, S4, and S8).

    Journal: MedComm

    Article Title: Discovery of a First‐in‐Class Murine Double Minute 2‐Recruiting Positive Transcription Elongation Factor B PROTAC Degrader With Selective Antitumor Activity

    doi: 10.1002/mco2.70723

    Figure Lengend Snippet: Selective activities of compounds 12 (dCDK9‐009) and 13 (dCDK9‐010) against TP53 wild‐type cancer cells. (A and B) Examination of dose‐dependent impacts of dCDK9‐009 and dCDK9‐010 in TP53 wild‐type HCT116, HT1080, NCI‐H460, and U87. Cells were treated with increasing concentrations of indicated compounds for 24 h. (C and D) Examination of impacts of dCDK9‐009 and dCDK9‐010 in non‐malignant HEK293T and mesenchymal stem cell line ASC52telo. Cells were treated with increasing concentrations of indicated compounds for 24 h. (E and F) Effect of dCDK9‐009 and dCDK9‐010 treatment on cellular viabilities of indicated cancer cell lines, as well as ASC52telo. IC 50 was presented as mean ± SD with three independent replicates. (G) Heatmap summarizing the IC 50 values of dCDK9‐009 and dCDK9‐010 across human cell lines tested in this study (related to E and F, Figures S3, S4, and S8).

    Article Snippet: NCI‐H460 (ATCC), NCI‐H226 (ATCC), NCI‐H1299 (ATCC), KYSE‐150 (DSMZ, Germany), DLD‐1 (ATCC), THP‐1 (ATCC), NALM6 (ATCC), and REH (ATCC) cells were maintained in Roswell Park Memorial Institute medium 1640 (RPMI‐1640; Meilunbio, Dalian, China).

    Techniques: